首页 > 最新文献

Australasian Journal of Dermatology最新文献

英文 中文
Grenz Ray Therapy for Darier Disease and Hailey-Hailey Disease: A Case Series of Three Patients 格伦兹射线治疗达利尔病和黑利-黑利病:3例病例系列。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-26 DOI: 10.1111/ajd.14407
Conor Larney, Dale Jobson, Michael Webster
{"title":"Grenz Ray Therapy for Darier Disease and Hailey-Hailey Disease: A Case Series of Three Patients","authors":"Conor Larney, Dale Jobson, Michael Webster","doi":"10.1111/ajd.14407","DOIUrl":"10.1111/ajd.14407","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 1","pages":"e28-e31"},"PeriodicalIF":2.2,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142891579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing Dermatological Practice Through Photography: Essential Techniques and Tools 通过摄影加强皮肤科实践:基本技术和工具。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-24 DOI: 10.1111/ajd.14408
Ishana Dixit, Elizabeth Dawes-Higgs

Clinical photography plays a crucial role in dermatology by aiding in diagnosis, monitoring treatment progress and providing valuable visual documentation for research and patient education. This article outlines key photographic techniques, equipment options and best practices tailored for dermatologists to improve clinical outcomes through high-quality imagery.

临床摄影在皮肤病学中起着至关重要的作用,它有助于诊断,监测治疗进展,为研究和患者教育提供有价值的视觉记录。本文概述了关键的摄影技术,设备的选择和最佳实践为皮肤科医生量身定制,以提高临床结果通过高质量的图像。
{"title":"Enhancing Dermatological Practice Through Photography: Essential Techniques and Tools","authors":"Ishana Dixit,&nbsp;Elizabeth Dawes-Higgs","doi":"10.1111/ajd.14408","DOIUrl":"10.1111/ajd.14408","url":null,"abstract":"<div>\u0000 \u0000 <p>Clinical photography plays a crucial role in dermatology by aiding in diagnosis, monitoring treatment progress and providing valuable visual documentation for research and patient education. This article outlines key photographic techniques, equipment options and best practices tailored for dermatologists to improve clinical outcomes through high-quality imagery.</p>\u0000 </div>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 1","pages":"21-24"},"PeriodicalIF":2.2,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142880915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistent urticarial eruption preceding systemic features of adult-onset Still's disease: A case report. 成人发病斯蒂尔氏病系统性特征前持续性荨麻疹爆发1例报告。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-23 DOI: 10.1111/ajd.14397
Amreeta Kaur, Mathuja Bavanendrakumar, Shereen Oon, Emma Veysey

Adult-onset Still's disease (AOSD) is a rare autoinflammatory systemic disorder classically characterised by inflammatory polyarthritis, daily fevers and a transient asymptomatic salmon-pink maculopapular rash that typically arises with the onset of fevers. We report a case of AOSD presenting with a severely pruritic urticarial eruption starting 6 weeks prior to the onset of fever and arthritis and complicated by macrophage activation syndrome. This case highlights the importance of early recognition of diverse cutaneous manifestations of AOSD to facilitate timely diagnosis and treatment to improve disease outcomes.

成人发病的斯蒂尔氏病(AOSD)是一种罕见的自身炎症性全身性疾病,典型特征为炎症性多关节炎,每日发烧和一过性无症状的鲑鱼粉红色斑疹,通常在发烧时出现。我们报告了一例AOSD,在发烧和关节炎发作前6周出现严重瘙痒性荨麻疹疹,并伴有巨噬细胞激活综合征。本病例强调了早期识别AOSD各种皮肤表现的重要性,有助于及时诊断和治疗,改善疾病预后。
{"title":"Persistent urticarial eruption preceding systemic features of adult-onset Still's disease: A case report.","authors":"Amreeta Kaur, Mathuja Bavanendrakumar, Shereen Oon, Emma Veysey","doi":"10.1111/ajd.14397","DOIUrl":"https://doi.org/10.1111/ajd.14397","url":null,"abstract":"<p><p>Adult-onset Still's disease (AOSD) is a rare autoinflammatory systemic disorder classically characterised by inflammatory polyarthritis, daily fevers and a transient asymptomatic salmon-pink maculopapular rash that typically arises with the onset of fevers. We report a case of AOSD presenting with a severely pruritic urticarial eruption starting 6 weeks prior to the onset of fever and arthritis and complicated by macrophage activation syndrome. This case highlights the importance of early recognition of diverse cutaneous manifestations of AOSD to facilitate timely diagnosis and treatment to improve disease outcomes.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allergens in ophthalmic medicaments in New Zealand 新西兰眼科药物中的过敏原。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-23 DOI: 10.1111/ajd.14395
Carneshika Bernadette Hettiaratchi BSc, MBChB, Harriet Kennedy BHB, MBChB, FRACP

Background/Objectives

Eyelid allergic contact dermatitis (ACD) attributed to ophthalmic medications is often underreported, which can result in poor outcomes. Patch testing for eyelid ACD requires up-to-date knowledge of potential allergens. The aim of this study was to investigate allergens in ophthalmic medicaments in New Zealand.

Methods

We conducted a cross-sectional review of ophthalmic medicaments available in New Zealand in October 2023. Prescription and over-the-counter products were catalogued with their respective ingredient lists according to product data sheets. Products unapproved for use as per Section 29 of the Medicines Act 1981, or that were unavailable for purchase were excluded. Ingredients were classified according to their function. Allergens in the New Zealand Baseline Series Extended (NZBSE) were recorded.

Results

Seventy-three topical ophthalmic medicaments were identified with a total of 143 formulations (brands). Twenty-eight formulations were excluded, leaving a total of 67 topical medicaments (115 formulations) for analysis. Fifty-eight per cent of formulations contained at least one NZBSE allergen. The most frequently identified NZBSE allergen was benzalkonium chloride (contained in 48% of formulations), followed by propylene glycol (6%), lanolin (4%), parabens (4%), caine anaesthetics (2%), neomycin sulphate (2%), and cetearyl alcohol (1%).

Conclusions

The majority of ophthalmic preparations contain known allergens. Patch test series must be based on local data and revised regularly to ensure the diagnostic accuracy of patch testing. Patch testing patient's own products is imperative.

背景/目的:眼科药物引起的眼睑过敏性接触性皮炎(ACD)经常被低估,这可能导致不良的预后。眼睑ACD的贴片测试需要最新的潜在过敏原知识。本研究的目的是调查新西兰眼科药物中的过敏原。方法:我们对2023年10月新西兰可用的眼科药物进行了横断面回顾。处方药和非处方药根据产品数据表进行分类,并附有各自的成分表。根据《1981年药品法案》第29条未批准使用的产品或无法购买的产品不包括在内。成分按其功能分类。记录新西兰基线系列扩展(NZBSE)中的过敏原。结果:鉴定出73种眼用药物,共143个剂型(品牌)。28种制剂被排除在外,总共留下67种外用药物(115种制剂)供分析。58%的配方含有至少一种NZBSE过敏原。最常见的NZBSE过敏原是苯甲氯铵(含有48%的配方),其次是丙二醇(6%)、羊毛脂(4%)、对羟基苯甲酸酯(4%)、卡因麻醉剂(2%)、硫酸新霉素(2%)和蜡醇(1%)。结论:大多数眼科制剂含有已知的过敏原。补丁测试系列必须以当地数据为基础,并定期修订,以保证补丁测试诊断的准确性。对患者自己的产品进行补丁测试是必要的。
{"title":"Allergens in ophthalmic medicaments in New Zealand","authors":"Carneshika Bernadette Hettiaratchi BSc, MBChB,&nbsp;Harriet Kennedy BHB, MBChB, FRACP","doi":"10.1111/ajd.14395","DOIUrl":"10.1111/ajd.14395","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background/Objectives</h3>\u0000 \u0000 <p>Eyelid allergic contact dermatitis (ACD) attributed to ophthalmic medications is often underreported, which can result in poor outcomes. Patch testing for eyelid ACD requires up-to-date knowledge of potential allergens. The aim of this study was to investigate allergens in ophthalmic medicaments in New Zealand.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a cross-sectional review of ophthalmic medicaments available in New Zealand in October 2023. Prescription and over-the-counter products were catalogued with their respective ingredient lists according to product data sheets. Products unapproved for use as per Section 29 of the Medicines Act 1981, or that were unavailable for purchase were excluded. Ingredients were classified according to their function. Allergens in the New Zealand Baseline Series Extended (NZBSE) were recorded.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Seventy-three topical ophthalmic medicaments were identified with a total of 143 formulations (brands). Twenty-eight formulations were excluded, leaving a total of 67 topical medicaments (115 formulations) for analysis. Fifty-eight per cent of formulations contained at least one NZBSE allergen. The most frequently identified NZBSE allergen was benzalkonium chloride (contained in 48% of formulations), followed by propylene glycol (6%), lanolin (4%), parabens (4%), caine anaesthetics (2%), neomycin sulphate (2%), and cetearyl alcohol (1%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The majority of ophthalmic preparations contain known allergens. Patch test series must be based on local data and revised regularly to ensure the diagnostic accuracy of patch testing. Patch testing patient's own products is imperative.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 1","pages":"14-20"},"PeriodicalIF":2.2,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-centre retrospective review of dupilumab-induced ocular surface disease in an Australian adult cohort with moderate-to-severe atopic dermatitis 单中心回顾性评价dupilumab诱导的澳大利亚成人中至重度特应性皮炎眼表疾病。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-16 DOI: 10.1111/ajd.14400
Alexis Arasu, Andrew Awad, Vanessa Tran, Gayle Ross

Treatment and management outcomes or patients with atopic dermatitis has significantly improved with the inclusion of dupilumab into the pharmaceutical benefits scheme, as a safe and effective treatment. Ocular surface disease remains one of the most frequent adverse events seen with dupilumab, and impacts quality of life and can interrupt treatment. This retrospective review aims to further characterise the experience and risk factors of dupilumab-induced ocular surface disease to inform management and support long-term use for patients, improving overall treatment outcomes.

特应性皮炎患者的治疗和管理结果随着dupilumab作为一种安全有效的治疗方法纳入药物获益方案而显著改善。眼表疾病仍然是dupilumab最常见的不良事件之一,影响生活质量并可能中断治疗。本回顾性研究旨在进一步描述dupilumab诱导的眼表疾病的经历和危险因素,为管理提供信息,并支持患者的长期使用,改善总体治疗结果。
{"title":"Single-centre retrospective review of dupilumab-induced ocular surface disease in an Australian adult cohort with moderate-to-severe atopic dermatitis","authors":"Alexis Arasu,&nbsp;Andrew Awad,&nbsp;Vanessa Tran,&nbsp;Gayle Ross","doi":"10.1111/ajd.14400","DOIUrl":"10.1111/ajd.14400","url":null,"abstract":"<p>Treatment and management outcomes or patients with atopic dermatitis has significantly improved with the inclusion of dupilumab into the pharmaceutical benefits scheme, as a safe and effective treatment. Ocular surface disease remains one of the most frequent adverse events seen with dupilumab, and impacts quality of life and can interrupt treatment. This retrospective review aims to further characterise the experience and risk factors of dupilumab-induced ocular surface disease to inform management and support long-term use for patients, improving overall treatment outcomes.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 1","pages":"e24-e27"},"PeriodicalIF":2.2,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory Vulvovaginal Lichen Planus Responding to Oral Tofacitinib. 口服托法替尼治疗难治性外阴阴道扁平苔藓。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-16 DOI: 10.1111/ajd.14403
Benetta Benny, Anupama Bains, Aasma Nalwa

Erosive vulvovaginal lichen planus is a severe form of Lichen planus (LP) that can result in chronic scarring if not treated. It can cause narrowing of the introitus, resulting in pain, itch, dyspareunia, dysuria, and recurrent urinary tract infections caused by retention of urine. Therefore, an effective and safer therapeutic approach is required. Here, we present a case of refractory erosive vulvovaginal LP, which showed remarkable response to oral tofacitinib, a Janus kinase 1 and 3 (JAK1/3) inhibitor, which was well tolerated.

糜烂外阴阴道扁平苔藓是一种严重形式的扁平苔藓(LP),可导致慢性疤痕,如果不治疗。它会引起尿道狭窄,导致疼痛、瘙痒、性交困难、排尿困难和尿潴留引起的反复尿路感染。因此,需要一种有效和安全的治疗方法。在这里,我们报告了一例难治性糜烂性外阴阴道LP,该病例对口服托法替尼(一种Janus激酶1和3 (JAK1/3)抑制剂)有显著的反应,耐受性良好。
{"title":"Refractory Vulvovaginal Lichen Planus Responding to Oral Tofacitinib.","authors":"Benetta Benny, Anupama Bains, Aasma Nalwa","doi":"10.1111/ajd.14403","DOIUrl":"https://doi.org/10.1111/ajd.14403","url":null,"abstract":"<p><p>Erosive vulvovaginal lichen planus is a severe form of Lichen planus (LP) that can result in chronic scarring if not treated. It can cause narrowing of the introitus, resulting in pain, itch, dyspareunia, dysuria, and recurrent urinary tract infections caused by retention of urine. Therefore, an effective and safer therapeutic approach is required. Here, we present a case of refractory erosive vulvovaginal LP, which showed remarkable response to oral tofacitinib, a Janus kinase 1 and 3 (JAK1/3) inhibitor, which was well tolerated.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of bilateral symmetrical broad-based acquired ungual fibrokeratomas 罕见的双侧对称广泛性获得性跖骨纤维角瘤1例。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-13 DOI: 10.1111/ajd.14392
Ankit Gupta MBBS (Hons), FRACGP, Nicholas Manuelpillai MBBS, B.Eng (Hons), B.Comm, MPH(Epi), Sara Lee de Menezes MBBS (Hons) MPhil FACD, Saurabh Prakash MBChB, FRCPA, ICDP-UEMS (Dermpath), Hon FACD, Johannes Steffen Kern MD, PhD, ICDP-UEMS (Dermpath), FEBDV, FACD
{"title":"A rare case of bilateral symmetrical broad-based acquired ungual fibrokeratomas","authors":"Ankit Gupta MBBS (Hons), FRACGP,&nbsp;Nicholas Manuelpillai MBBS, B.Eng (Hons), B.Comm, MPH(Epi),&nbsp;Sara Lee de Menezes MBBS (Hons) MPhil FACD,&nbsp;Saurabh Prakash MBChB, FRCPA, ICDP-UEMS (Dermpath), Hon FACD,&nbsp;Johannes Steffen Kern MD, PhD, ICDP-UEMS (Dermpath), FEBDV, FACD","doi":"10.1111/ajd.14392","DOIUrl":"10.1111/ajd.14392","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 1","pages":"45-47"},"PeriodicalIF":2.2,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142816829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The two-step method of digital follow-up of bland skin lesions is a safe and useful tool in melanoma diagnosis 对平淡无奇的皮肤病变进行数字跟踪的两步法是诊断黑色素瘤的一种安全而有用的工具。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-13 DOI: 10.1111/ajd.14390
Cliff Rosendahl MBBS PhD, Christine Lee Bachelor Nursing, SFC (Skin Cancer Diagnostics), Sarah Coleman Grad Cert Nursing, SFC (Skin Cancer Diagnostics), Aksana Marozava MD, Blake O'Brien MBBS FRCPA
{"title":"The two-step method of digital follow-up of bland skin lesions is a safe and useful tool in melanoma diagnosis","authors":"Cliff Rosendahl MBBS PhD,&nbsp;Christine Lee Bachelor Nursing, SFC (Skin Cancer Diagnostics),&nbsp;Sarah Coleman Grad Cert Nursing, SFC (Skin Cancer Diagnostics),&nbsp;Aksana Marozava MD,&nbsp;Blake O'Brien MBBS FRCPA","doi":"10.1111/ajd.14390","DOIUrl":"10.1111/ajd.14390","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 1","pages":"48-49"},"PeriodicalIF":2.2,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142823731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic basal cell carcinomas in Gorlin syndrome—A case series and literature review Gorlin综合征中的转移性基底细胞癌——病例系列及文献回顾。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-12 DOI: 10.1111/ajd.14401
Usamah M. Afzal MD, Faisal R. Ali MD FRCP PhD, Deemesh Oudit FRCSEd, Roxana Totorean MD, Gareth Evans MD FRCP, John T. Lear FRCP PhD

Metastatic basal cell carcinomas (mBCCs) are exceedingly rare, with an estimated variable prevalence rate between 0.003 and 0.55% among all basal cell carcinomas. Although there are hundreds of reported cases of mBCCs, a dearth of evidence exists of mBCCs in patients with Gorlin syndrome—an autosomal dominant genetic disorder. The purpose of this article was to present the first and largest case series of patients with mBCC in Gorlin. A literature review (LR) compares our data with the existing evidence base to underscore the importance of early surveillance, diagnosis and surgical intervention of suspicious lesions as distant metastases significantly reduce survival rates.

转移性基底细胞癌(mbcc)非常罕见,在所有基底细胞癌中,估计可变患病率在0.003%至0.55%之间。尽管有数百例报道的mbcc病例,但缺乏证据表明mbcc存在于Gorlin综合征(一种常染色体显性遗传疾病)患者中。本文的目的是介绍Gorlin地区mBCC患者的第一个也是最大的病例系列。一篇文献综述(LR)将我们的数据与现有的证据基础进行了比较,强调了早期监测、诊断和手术干预可疑病变的重要性,因为远处转移会显著降低生存率。
{"title":"Metastatic basal cell carcinomas in Gorlin syndrome—A case series and literature review","authors":"Usamah M. Afzal MD,&nbsp;Faisal R. Ali MD FRCP PhD,&nbsp;Deemesh Oudit FRCSEd,&nbsp;Roxana Totorean MD,&nbsp;Gareth Evans MD FRCP,&nbsp;John T. Lear FRCP PhD","doi":"10.1111/ajd.14401","DOIUrl":"10.1111/ajd.14401","url":null,"abstract":"<p>Metastatic basal cell carcinomas (mBCCs) are exceedingly rare, with an estimated variable prevalence rate between 0.003 and 0.55% among all basal cell carcinomas. Although there are hundreds of reported cases of mBCCs, a dearth of evidence exists of mBCCs in patients with Gorlin syndrome—an autosomal dominant genetic disorder. The purpose of this article was to present the first and largest case series of patients with mBCC in Gorlin. A literature review (LR) compares our data with the existing evidence base to underscore the importance of early surveillance, diagnosis and surgical intervention of suspicious lesions as distant metastases significantly reduce survival rates.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 1","pages":"36-39"},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Switching within the class of IL-17 inhibitors for the treatment of plaque psoriasis: A real-world retrospective study. 切换IL-17抑制剂治疗斑块型银屑病:一项真实世界的回顾性研究
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-12-12 DOI: 10.1111/ajd.14396
Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Maria Politou, Alexander Stratigos, Electra Nicolaidou
{"title":"Switching within the class of IL-17 inhibitors for the treatment of plaque psoriasis: A real-world retrospective study.","authors":"Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Maria Politou, Alexander Stratigos, Electra Nicolaidou","doi":"10.1111/ajd.14396","DOIUrl":"https://doi.org/10.1111/ajd.14396","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Australasian Journal of Dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1